Sutro Biopharma (STRO) support and resistance · rev $62.0M
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
This page maps Sutro Biopharma (STRO) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
STRO currently screens at market cap $470.8M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new STRO 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the STRO quote page for the session range and the stock page for the full model.
Not investment advice.